These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 3607751

  • 21. [Endocrine therapy of lung cancer].
    Sagara N, Hara S, Nakano K, Haeno Y, Mori N, Aisawa M, Kurooka K, Matuda T, Wada T, Shindou K.
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):859-61. PubMed ID: 2712581
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Heterogeneity in the hormonal responsiveness of clones derived from the 13762NF rat mammary tumor.
    Geradts J, Richards J, Edery M, Pang K, Larson L, Nandi S.
    Cancer Res; 1986 Apr; 46(4 Pt 2):1920-7. PubMed ID: 3004710
    [Abstract] [Full Text] [Related]

  • 24. Unique male mammary tumors developing in the inbred soft-furred field rats Millardia meltada.
    Lu J, Aoyama A, Hoshino M, Tsuchiya K, Taguchi O, Matsuyama M, Kojima A.
    Am J Pathol; 1989 Sep; 135(3):477-88. PubMed ID: 2551171
    [Abstract] [Full Text] [Related]

  • 25. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR, Boeddinghaus IM, Riddler S, Haynes BP, Hardcastle IR, Rowlands M, Grimshaw R, Jarman M, Dowsett M.
    Cancer Res; 1999 Aug 01; 59(15):3646-51. PubMed ID: 10446976
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activation.
    Gattelli A, Cirio MC, Quaglino A, Schere-Levy C, Martinez N, Binaghi M, Meiss RP, Castilla LH, Kordon EC.
    Cancer Res; 2004 Aug 01; 64(15):5193-9. PubMed ID: 15289324
    [Abstract] [Full Text] [Related]

  • 28. 3H-thymidine incorporation into mammary carcinoma cells obtained by needle aspiration before and during endocrine therapy.
    Nordenskjöld B, Löwhagen T, Westerberg H, Zajicek J.
    Acta Cytol; 1976 Aug 01; 20(2):137-43. PubMed ID: 1065173
    [Abstract] [Full Text] [Related]

  • 29. Spontaneous and estrogen-produced tumors in Nb rats and their behavior after transplantation.
    Noble RL, Hochachka BC, King D.
    Cancer Res; 1975 Mar 01; 35(3):766-80. PubMed ID: 1167809
    [Abstract] [Full Text] [Related]

  • 30. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC.
    Clin Cancer Res; 2000 May 01; 6(5):2028-36. PubMed ID: 10815929
    [Abstract] [Full Text] [Related]

  • 31. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
    Sylvester PW, Aylsworth CF, Van Vugt DA, Meites J.
    Cancer Res; 1983 Nov 01; 43(11):5342-6. PubMed ID: 6413057
    [Abstract] [Full Text] [Related]

  • 32. Apoptosis and necrosis occurring during different stages of primary and metastatic tumor growth of a rat mammary adenocarcinoma.
    Matsuda H, Strebel FR, Kaneko T, Stephens LC, Danhauser LL, Jenkins GN, Toyota N, Bull JM.
    Anticancer Res; 1996 Nov 01; 16(3A):1117-21. PubMed ID: 8702222
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol.
    Jacobson HI, Bennett JA, Mizejewski GJ.
    Cancer Res; 1990 Jan 15; 50(2):415-20. PubMed ID: 1688512
    [Abstract] [Full Text] [Related]

  • 34. Phenotypic change of the transplantable MXT mammary adenocarcinoma into mixed bone producing sarcoma-like tumors.
    Kiss R, Devleeschouwer N, Paridaens RJ, Danguy A, Heuson JC, Atassi G.
    Anticancer Res; 1986 Jan 15; 6(4):753-9. PubMed ID: 3463244
    [Abstract] [Full Text] [Related]

  • 35. Polyamines and hormonal regulation of N-nitrosomethylurea-induced rat mammary tumor growth in vivo.
    Manni A, Wright C, Demers L, Luk G.
    Cancer Res; 1986 Oct 15; 46(10):4938-41. PubMed ID: 3756855
    [Abstract] [Full Text] [Related]

  • 36. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
    George DJ, Dionne CA, Jani J, Angeles T, Murakata C, Lamb J, Isaacs JT.
    Cancer Res; 1999 May 15; 59(10):2395-401. PubMed ID: 10344749
    [Abstract] [Full Text] [Related]

  • 37. Isolation of a stromal cell line from an early passage of a mouse mammary tumor line: a model for stromal parenchymal interactions.
    Lamb CA, Fabris V, Gorostiaga MA, Helguero LA, Efeyan A, Bottino MC, Simian M, Soldati R, Sanjuan N, Molinolo A, Lanari C.
    J Cell Physiol; 2005 Mar 15; 202(3):672-82. PubMed ID: 15389583
    [Abstract] [Full Text] [Related]

  • 38. N-methyl-N-nitrosourea-induced rat mammary tumors. Hormone responsiveness but lack of spontaneous metastasis.
    Williams JC, Gusterson B, Humphreys J, Monaghan P, Coombes RC, Rudland P, Neville AM.
    J Natl Cancer Inst; 1981 Jan 15; 66(1):147-55. PubMed ID: 6779042
    [Abstract] [Full Text] [Related]

  • 39. Production of Nb rat carcinoma of the dorsal prostate and response of estrogen-dependent transplants to sex hormones and tamoxifen.
    Noble RL.
    Cancer Res; 1980 Oct 15; 40(10):3547-50. PubMed ID: 7438041
    [Abstract] [Full Text] [Related]

  • 40. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J, Sommer A.
    J Steroid Biochem Mol Biol; 2005 Feb 15; 93(2-5):191-200. PubMed ID: 15860262
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.